Search Results - Jun Horiguchi

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    May Salivary Alpha-Amylase Level Be a Useful Tool for Assessment of the Severity of Schizophrenia and Evaluation of Therapy? A Case Report by Masa Ieda, Tsuyoshi Miyaoka, Kiminori Kawano, Rei Wake, Takuji Inagaki, Jun Horiguchi

    Published in Case Reports in Psychiatry (2012-01-01)
    Get full text
    Article


  2. 2

    A multicenter, double‐blind, randomized, controlled study of patients with treatment‐resistant schizophrenia treated with yokukansan for 12 weeks by Jun Horiguchi, Rei Wake, Kenta Murotani, Haruo Seno, Tsuyoshi Miyaoka, Ken Inoue

    Published in PCN Reports (2023-12-01)
    Get full text
    Article


  3. 3

    Salivary Alpha-Amylase Activity Levels in Catatonic Schizophrenia Decrease after Electroconvulsive Therapy by Misako Kanayama, Tsuyoshi Miyaoka, Tomoko Araki, Maiko Hayashida, Sadayuki Hashioka, Jun Horiguchi

    Published in Case Reports in Psychiatry (2018-01-01)
    Get full text
    Article


  4. 4

    RNA‐sequence‐based microRNA expression signature in breast cancer: tumor‐suppressive miR‐101‐5p regulates molecular pathogenesis by Hiroko Toda, Naohiko Seki, Sasagu Kurozumi, Yoshiaki Shinden, Yasutaka Yamada, Nijiro Nohata, Shogo Moriya, Tetsuya Idichi, Kosei Maemura, Takaaki Fujii, Jun Horiguchi, Yuko Kijima, Shoji Natsugoe

    Published in Molecular Oncology (2020-02-01)
    Get full text
    Article


  5. 5

    Fibrocystic breast disease with pleomorphic calcifications and segmental distribution: A case report by Kuo JiueLan, MD, Chikako Sekine, MD, PhD, Sasagu Kurozumi, MD, PhD, Ryosuke Matsuoka, MD, Mina Komuta, MD, PhD, Takayuki Shiomi, MD, PhD, Jun Horiguchi, MD, PhD

    Published in Radiology Case Reports (2023-11-01)
    Get full text
    Article


Search Tools: